Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
26 07 2022
Historique:
received: 24 05 2022
accepted: 01 07 2022
revised: 28 06 2022
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profiles and outcome features. However, the extent of neuroanatomical heterogeneity in the CHR-P state is largely undetermined. We aimed to quantify the neuroanatomical heterogeneity in structural magnetic resonance imaging measures of cortical surface area (SA), cortical thickness (CT), subcortical volume (SV), and intracranial volume (ICV) in CHR-P individuals compared with healthy controls (HC), and in relation to subsequent transition to a first episode of psychosis. The ENIGMA CHR-P consortium applied a harmonised analysis to neuroimaging data across 29 international sites, including 1579 CHR-P individuals and 1243 HC, offering the largest pooled CHR-P neuroimaging dataset to date. Regional heterogeneity was indexed with the Variability Ratio (VR) and Coefficient of Variation (CV) ratio applied at the group level. Personalised estimates of heterogeneity of SA, CT and SV brain profiles were indexed with the novel Person-Based Similarity Index (PBSI), with two complementary applications. First, to assess the extent of within-diagnosis similarity or divergence of neuroanatomical profiles between individuals. Second, using a normative modelling approach, to assess the 'normativeness' of neuroanatomical profiles in individuals at CHR-P. CHR-P individuals demonstrated no greater regional heterogeneity after applying FDR corrections. However, PBSI scores indicated significantly greater neuroanatomical divergence in global SA, CT and SV profiles in CHR-P individuals compared with HC. Normative PBSI analysis identified 11 CHR-P individuals (0.70%) with marked deviation (>1.5 SD) in SA, 118 (7.47%) in CT and 161 (10.20%) in SV. Psychosis transition was not significantly associated with any measure of heterogeneity. Overall, our examination of neuroanatomical heterogeneity within the CHR-P state indicated greater divergence in neuroanatomical profiles at an individual level, irrespective of psychosis conversion. Further large-scale investigations are required of those who demonstrate marked deviation.

Identifiants

pubmed: 35882855
doi: 10.1038/s41398-022-02057-y
pii: 10.1038/s41398-022-02057-y
pmc: PMC9325730
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

297

Subventions

Organisme : NIH HHS
ID : R01AG058854
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH107558
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH113619
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002387
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH117434
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113533
Pays : United States
Organisme : NIH HHS
ID : P41EB015922
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH115332
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH116147
Pays : United States
Organisme : Department of Health
Pays : United Kingdom

Investigateurs

Camilo de la Fuente-Sandoval (C)
Sabrina Catalano (S)
Daniela Hubl (D)
Jason Schiffman (J)
Enea D Venegoni (ED)
Christine I Hooker (CI)
Paul E Rasser (PE)
Wenche Ten Velden Hegelstad (WTV)
Franz Resch (F)
Imke L J Lemmers-Jansen (ILJ)
G Paul Amminger (GP)
Xiaogang Chen (X)
Kang Ik K Cho (KIK)
Birte Yding Glenthøj (BY)
Lieuwe de Haan (L)
Matthew A Harris (MA)
Wu Jeong Hwang (WJ)
Pablo León-Ortiz (P)
Xiaoqian Ma (X)
Patrick McGorry (P)
Ricardo Mora-Durán (R)
Masafumi Mizuno (M)
Merete Nordentoft (M)
Lijun Ouyang (L)
Jose C Pariente (JC)
Francisco Reyes-Madrigal (F)
Mikkel E Sørensen (ME)
Dennis Velakoulis (D)
Sophia Vinogradov (S)
Christina Wenneberg (C)
Hidenori Yamasue (H)
Liu Yuan (L)
Alison R Yung (AR)

Informations de copyright

© 2022. The Author(s).

Références

PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Schizophr Res. 2021 Jan;227:4-9
pubmed: 32527679
J Child Psychol Psychiatry. 2021 May;62(5):657-673
pubmed: 32924144
Schizophr Bull. 2016 May;42(3):732-43
pubmed: 26591006
J Affect Disord. 2020 Nov 1;276:38-44
pubmed: 32697714
Am J Psychiatry. 2011 Aug;168(8):800-5
pubmed: 21498462
J Psychiatr Res. 2011 Feb;45(2):190-8
pubmed: 20580022
Neurosci Biobehav Rev. 2011 Apr;35(5):1175-85
pubmed: 21168439
J Affect Disord. 2016 Oct;203:101-110
pubmed: 27285723
Transl Psychiatry. 2021 Jan 13;11(1):43
pubmed: 33441556
JAMA Psychiatry. 2020 Jul 1;77(7):755-765
pubmed: 32159746
Schizophr Res. 2019 Jul;209:22-31
pubmed: 31104914
Psychiatr Q. 1999 Winter;70(4):273-87
pubmed: 10587984
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Transl Psychiatry. 2019 Nov 14;9(1):300
pubmed: 31727878
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Cereb Cortex. 2019 Feb 1;29(2):852-862
pubmed: 30462205
Biol Psychiatry. 2016 Oct 1;80(7):552-61
pubmed: 26927419
IEEE Trans Med Imaging. 1998 Feb;17(1):87-97
pubmed: 9617910
EClinicalMedicine. 2020 Oct 07;28:100578
pubmed: 33294806
Lancet. 2003 Jan 25;361(9354):281-8
pubmed: 12559861
Eur Psychiatry. 2017 Feb;40:65-75
pubmed: 27992836
JAMA Psychiatry. 2021 Sep 1;78(9):970-978
pubmed: 34259821
Biol Psychiatry. 2020 Feb 1;87(3):234-242
pubmed: 31771861
Trends Cogn Sci. 2019 Jul;23(7):584-601
pubmed: 31153774
JAMA Psychiatry. 2021 Jul 1;78(7):753-766
pubmed: 33950164
Curr Pharm Des. 2012;18(32):5070-80
pubmed: 22716152
Schizophr Bull. 2017 Jan;43(1):44-47
pubmed: 28053129
Neuroimage. 2020 Sep;218:116956
pubmed: 32470572
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
JAMA Psychiatry. 2019 Oct 1;76(10):1063-1073
pubmed: 31158853
Front Psychiatry. 2014 Jan 29;4:187
pubmed: 24523700
World Psychiatry. 2017 Jun;16(2):200-206
pubmed: 28498576
JAMA Psychiatry. 2021 Jun 16;:
pubmed: 34132736
Schizophr Res. 2012 Dec;142(1-3):217-22
pubmed: 23123134
Br J Psychiatry. 2009 Sep;195(3):218-26
pubmed: 19721111
NPJ Schizophr. 2020 Dec 4;6(1):39
pubmed: 33277498
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
NPJ Schizophr. 2016 Sep 28;2:16033
pubmed: 27738647
JAMA Psychiatry. 2020 Feb 1;77(2):216-217
pubmed: 31693058
Child Adolesc Psychiatr Clin N Am. 2013 Oct;22(4):689-714
pubmed: 24012081
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
pubmed: 10984517
Schizophr Res. 2021 Jan;227:20-27
pubmed: 32467067
J Comput Assist Tomogr. 1994 Mar-Apr;18(2):192-205
pubmed: 8126267
Lancet Psychiatry. 2022 Jan;9(1):72-83
pubmed: 34856200
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Schizophr Bull. 2021 Jul 8;47(4):1029-1038
pubmed: 33547470
Hum Brain Mapp. 2017 Feb;38(2):704-714
pubmed: 27699911
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
pubmed: 16343296
JAMA Psychiatry. 2016 Mar;73(3):211-20
pubmed: 26764163
Neuroimage. 2010 Aug 1;52(1):62-8
pubmed: 20399273
JAMA Psychiatry. 2017 Nov 1;74(11):1104-1111
pubmed: 28973084
JAMA Psychiatry. 2016 Feb;73(2):113-20
pubmed: 26719911
JAMA Psychiatry. 2016 May 1;73(5):515-24
pubmed: 26982085
Eur Neuropsychopharmacol. 2012 Feb;22(2):114-22
pubmed: 21741803
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Early Interv Psychiatry. 2020 Dec;14(6):741-750
pubmed: 32067369
World Psychiatry. 2018 Feb;17(1):49-66
pubmed: 29352556
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):223-230
pubmed: 29486863
NPJ Schizophr. 2020 Oct 5;6(1):27
pubmed: 33020486
Neuroimage. 2004;23 Suppl 1:S69-84
pubmed: 15501102
Schizophr Bull. 2008 Mar;34(2):322-9
pubmed: 18199631
Schizophr Res. 2021 Jan;227:44-51
pubmed: 33131983
Mol Psychiatry. 2020 Nov;25(11):2773-2785
pubmed: 32066828
Schizophr Res. 2014 Sep;158(1-3):69-75
pubmed: 25012147
Neuroimage. 1999 Feb;9(2):195-207
pubmed: 9931269
Arch Gen Psychiatry. 2011 May;68(5):489-95
pubmed: 21536978
Epidemiol Psychiatr Sci. 2019 Nov 19;29:e67
pubmed: 31739812
Neuroimage. 2004 Jul;22(3):1060-75
pubmed: 15219578

Auteurs

Helen Baldwin (H)

Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. helen.baldwin@kcl.ac.uk.
National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK. helen.baldwin@kcl.ac.uk.

Joaquim Radua (J)

Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, CIBERSAM, Barcelona, Spain.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Mathilde Antoniades (M)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

Shalaila S Haas (SS)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

Sophia Frangou (S)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.

Ingrid Agartz (I)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Norwegian Centre for Mental Disorders Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
KG Jebsen Center for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.

Paul Allen (P)

Department of Psychology, University of Roehampton, London, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Ole A Andreassen (OA)

KG Jebsen Center for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.
NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Kimberley Atkinson (K)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Peter Bachman (P)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

Inmaculada Baeza (I)

Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, 2017SGR-881, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Universitat de Barcelona, Barcelona, Spain.

Cali F Bartholomeusz (CF)

Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Orygen, Melbourne, VIC, Australia.

Michael W L Chee (MWL)

Center for Sleep and Cognition, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Tiziano Colibazzi (T)

Department of Psychiatry, Columbia University, New York City, NY, USA.
New York State Psychiatric Institute, New York City, NY, USA.

Rebecca E Cooper (RE)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne & Melbourne Health, Carlton South, VIC, Australia.

Cheryl M Corcoran (CM)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Mental Illness Research, Education, and Clinical Center, James J Peters VA Medical Center, New York City, NY, USA.

Vanessa L Cropley (VL)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne & Melbourne Health, Carlton South, VIC, Australia.
Centre for Mental Health, Faculty of Health, Arts and Design, School of Health Sciences, Swinburne University, Melbourne, VIC, Australia.

Bjørn H Ebdrup (BH)

Centre for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Adriana Fortea (A)

Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic Barcelona, Fundació Clínic Recerca Biomèdica, Universitat de Barcelona, Barcelona, Spain.

Louise Birkedal Glenthøj (LB)

Copenhagen Research Center for Mental Health, Mental Health Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.

Holly K Hamilton (HK)

Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.
San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA.

Kristen M Haut (KM)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Rebecca A Hayes (RA)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

Ying He (Y)

National Clinical Research Center for Mental Disorders and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Karsten Heekeren (K)

Department of Psychiatry and Psychotherapy I, LVR-Hospital Cologne, Cologne, Germany.
Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Michael Kaess (M)

Department of Child and Adolescent Psychiatry, Center of Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany.
University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.

Kiyoto Kasai (K)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo Institute for Diversity and Adaptation of Human Mind, Tokyo, Japan.
The International Research Center for Neurointelligence at The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.

Naoyuki Katagiri (N)

Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.

Minah Kim (M)

Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.

Jochen Kindler (J)

University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.

Mallory J Klaunig (MJ)

Department of Psychology, University of Maryland, Baltimore County, MD, USA.

Shinsuke Koike (S)

The University of Tokyo Institute for Diversity and Adaptation of Human Mind, Tokyo, Japan.
Center for Evolutionary Cognitive Sciences, Graduate School of Art and Sciences, The University of Tokyo, Tokyo, Japan.

Alex Koppel (A)

Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.

Tina D Kristensen (TD)

Centre for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, Denmark.
Copenhagen Research Center for Mental Health, Mental Health Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.

Yoo Bin Kwak (Y)

Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea.
Department of Psychosis, Institute of Mental Health, Singapore, Singapore.

Jun Soo Kwon (JS)

Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.

Stephen M Lawrie (SM)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Irina Lebedeva (I)

Laboratory of Neuroimaging and Multimodal Analysis, Mental Health Research Center, Moscow, Russian Federation.

Jimmy Lee (J)

Department of Psychosis, Institute of Mental Health, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Ashleigh Lin (A)

Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia.

Rachel L Loewy (RL)

Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.

Daniel H Mathalon (DH)

Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.
San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA.

Chantal Michel (C)

University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.

Romina Mizrahi (R)

Douglas Research Center, Montreal, QC, Canada.
Department of Psychiatry, McGill University, Montreal, QC, Canada.

Paul Møller (P)

Department for Mental Health Research and Development, Division of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway.

Barnaby Nelson (B)

Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Orygen, Melbourne, VIC, Australia.

Takahiro Nemoto (T)

Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.

Dorte Nordholm (D)

Copenhagen Research Center for Mental Health, Mental Health Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.

Maria A Omelchenko (MA)

Department of Youth Psychiatry, Mental Health Research Center, Moscow, Russian Federation.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne & Melbourne Health, Carlton South, VIC, Australia.
Florey Institute of Neuroscience and Mental Health, Center for Mental Health, Parkville, VIC, Australia.

Jayachandra M Raghava (JM)

Centre for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, Denmark.
Department of Clinical Physiology, Nuclear Medicine and PET, Functional Imaging Unit, University of Copenhagen, Glostrup, Denmark.
Centre for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.

Jan I Røssberg (JI)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Wulf Rössler (W)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.

Dean F Salisbury (DF)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

Daiki Sasabayashi (D)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Research Center for Idling Brain Science, University of Toyama, Toyama, Japan.

Ulrich Schall (U)

Priority Centre for Brain and Mental Health Research, The University of Newcastle, Newcastle, NSW, Australia.
Priority Research Centre Grow Up Well, The University of Newcastle, Newcastle, NSW, Australia.

Lukasz Smigielski (L)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Department of Child and Adolescent Psychiatry, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Gisela Sugranyes (G)

Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, 2017SGR-881, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Universitat de Barcelona, Barcelona, Spain.

Michio Suzuki (M)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Research Center for Idling Brain Science, University of Toyama, Toyama, Japan.

Tsutomu Takahashi (T)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Research Center for Idling Brain Science, University of Toyama, Toyama, Japan.

Christian K Tamnes (CK)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway.

Jinsong Tang (J)

Department of Psychiatry, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Medical Neurobiology of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China.

Anastasia Theodoridou (A)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Sophia I Thomopoulos (SI)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Alexander S Tomyshev (AS)

Laboratory of Neuroimaging and Multimodal Analysis, Mental Health Research Center, Moscow, Russian Federation.

Peter J Uhlhaas (PJ)

Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.

Tor G Værnes (TG)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Early Intervention in Psychosis Advisory Unit for South-East Norway, TIPS Sør-Øst, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Therese A M J van Amelsvoort (TAMJ)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Theo G M Van Erp (TGM)

Center for the Neurobiology of Learning and Memory, University of California Irvine, Irvine, CA, USA.
Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA.

James A Waltz (JA)

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA.

Lars T Westlye (LT)

KG Jebsen Center for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.
NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Stephen J Wood (SJ)

Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Orygen, Melbourne, VIC, Australia.
School of Psychology, University of Birmingham, Birmingham, UK.

Juan H Zhou (JH)

Center for Sleep and Cognition, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Center for Translational Magnetic Resonance Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Philip McGuire (P)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Maria Jalbrzikowski (M)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA.

Dennis Hernaus (D)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Paolo Fusar-Poli (P)

Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK.
OASIS Service, South London and Maudsley NHS Foundation Trust, London, UK.
Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH